Peptide Atlas · Peptide

ARA-290

ARA 290 (cibinetide) is a non-haematopoietic peptide designed from the structure of erythropoietin that interacts selectively with the innate repair receptor mediating tissue protection.

emerging

provisional
PubChem 91810664
2 citations
0 discussions
0 followers
Cibinetide
pHBSP (pyroglutamate Helix B Surface Peptide)

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for ARA-290. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
Randomized pilot in sarcoidosis-associated small fibre neuropathy (22 patients)	emerging	pmid 23168581
Phase 2: metabolic control and neuropathic symptoms improved in type 2 diabetes	emerging	pmid 25387363

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.